AbbVie (ABBV) — Entry Risk Score
Stock · re-scored every trading day · data as of 2026-11-12
The entry score measures one thing: how far AbbVie's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.
On 2026-11-12, AbbVie's price sits 0.75 ATR above its 20-day average ($289.17); it trades above its 200-day average ($240.41); its 14-day RSI is 64; it has moved +3.16% over 20 sessions; our regime filter classifies it as a strong uptrend.
Is AbbVie (ABBV) a buy right now?
AbbVie scores 78/98 (Accumulate) as of 2026-11-12; it is trading at its 52-week high; it is above its 200-day average; it moved +1.08% over the last 5 sessions. A mid-range score means the price is near its recent average: not a stretched entry, not a discount. Not investment advice.
Score history
Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.
| Date | Score | Δ | Close |
|---|---|---|---|
| 2026-11-12 | 78 | -1 | $294.45 |
| 2026-11-06 | 79 | -2 | $291.31 |
| 2026-11-05 | 81 | +10 | $288.24 |
| 2026-11-04 | 71 | -10 | $294.83 |
| 2026-11-03 | 81 | +1 | $286.00 |
| 2026-11-02 | 80 | +12 | $288.84 |
| 2026-10-29 | 68 | -11 | $290.79 |
| 2026-10-28 | 79 | +7 | $285.99 |
| 2026-10-27 | 72 | +4 | $286.39 |
| 2026-10-26 | 68 | +0 | $286.74 |
| 2026-10-23 | 68 | -2 | $285.64 |
| 2026-10-22 | 70 | +5 | $285.19 |
Congress trades in ABBV
STOCK Act disclosures by members of Congress, cross-referenced from our Smart Money tracker.
| Traded | Politician | Type | Amount | Return since |
|---|---|---|---|---|
| 2026-09-14 | Pete Sessions (R) | SALE | $15,001 - $50,000 | +11.3% |
| 2026-09-04 | Rohit Khanna (D) | SALE | $1,001 - $15,000 | +13.6% |
Related stocks
See today's full rankings + entry plan for ABBV →Get the Sunday Brief
One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.